SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins selloff amid concerns over a reported Binance security breach is weighing on Strategy shares, with traders debating whether the crypto-market shock signals deeper trouble or a buying opportunity. Concerns about Strategys quarterly results and CFO transition add to the bearish discussion, while some investors expect a rebound.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could decline after the TDAPA transition has fueled a sharp selloff and concerns about pricing and revenue. Traders disagree over the impact: some see a lasting commercial headwind, while others argue DaVitas outlook is preliminary and may overstate the risk; frustration with managements communication is also prominent.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak Q1 results, sharply reduced full-year outlook and dividend suspension have driven attention, as the company cited recession-level appliance demand and blamed the Iran war and collapsing consumer confidence. Many traders are alarmed by the worsening outlook and debt burden, while some see the selloff as an overreaction and are buying for a possible rebound.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has reached fresh 52-week highs, with traders focused on an expected Q3 earnings report and debating whether the rally reflects BRIUMVI growth expectations or speculative buyout hopes and short covering. The buyout talk remains unconfirmed, and the earnings date has not been officially confirmed.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Traders are focused on a possible update on Corvuss ALPS program around the ASH abstract release and a company call, though the timing and whether the data will be disclosed remain uncertain. Optimism about a potential catalyst is countered by concerns over past delays, managements limited updates and heavy short interest.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Weaker 2027 Medicare Advantage star ratings for Aetna are driving concern about lost bonus payments and future margin pressure. Traders are comparing CVSs weakness with Humanas rally on improved ratings, while debating whether the setback is already priced in.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RASONQUE (daraxonrasib), Revolution Medicines pancreatic cancer therapy, remains the main focus: traders cite its Phase 3 survival results and FDA approval as support for the companys commercial and broader RAS-drug pipeline prospects. Discussion is also divided over valuation and efficacy across KRAS subtypes, with some traders pointing to competition from selective G12D drugs such as Verastems VS-7375.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances updated NSCLC trial results and shift toward biomarker-selected lung-cancer studies are driving attention: the overall response rate was 24.6%, while a retrospective subgroup showed a stronger signal, but the lung-cancer filing is expected in 2027 and durability remains uncertain. Traders are divided between viewing the selloff as an overreaction to promising precision-treatment data and seeing a narrower, delayed opportunity compounded by managements confusing presentation.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples fiscal fourth-quarter earnings report is the focus, with traders debating whether its premium valuation can be justified amid memory-cost pressures and concerns about iPhone demand and upgrade cycles. Some expect a sharp post-report drop, while others view Apples restrained AI spending and relative resilience during the tech selloff as supporting its safe-haven appeal.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubos steep, low-volume decline and repeated new lows dominate the discussion, with many traders saying the selloff lacks a clear company-specific trigger. The community is looking to upcoming earnings and CEO Alisa Bowens strategic plan for clarity, while bears expect further downside and bulls argue for a turnaround or short-covering rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LI Stock Jumps as Li Auto Makes Its Second Launch This Month To Chase 20% Delivery Growth  

Equity

Li Auto called the i9 “a pioneering flagship family SUV.” The six-seat battery-electric vehicle is priced at RMB 369,800 for its standard configuration. 


LI Stock Continues To Hover Near 52-Week Low Despite New, Cheaper MPV Launch

The stock is currently trading around $11.88, just above its 52-week low of $11.65.

SERV Stock Rallies On Grubhub Partnership, DoorDash Deal Expansion — CEO Calls It 'Clearest Signal Yet Of Where We're Headed'

This comes as Serve Robotics looks to put more robots to work following its recent split with Uber Eats, with the company also launching a new micro-depot model and expanding beyond sidewalk delivery.


UMAC Stock Might See A 110% Rise From Current Levels, Says Analyst – What’s Driving The Bull Case?

According to TheFly, HC Wainwright initiated coverage of Unusual Machines with a ‘Buy’ rating and a price target of $42.


Nio Follows Tesla Playbook — Launches New Seating Configuration For Best-Selling SUV

Nio launched a five-seat version of its ES8 SUV on Thursday. 

FCEL Stock Headed For Best Single-Day Gains In Over A Year — Why UBS Tripled Its Price Target For FuelCell

UBS analyst Manav Gupta cited FuelCell’s recently announced strategic partnership with Fit Energy USA as the basis for the bullish outlook on the company.

XPEV Pops, LI Drops After Earnings: XPeng’s Cost Cuts Outshine Li Auto Discounts

Both XPeng and Li Auto reported a double-digit year-on-year decline in revenue, while still exceeding Wall Street expectations.

NRGV Stock Clocks Best Week In 8 Months: Retail Cheers 'Fruitful' Long-Term Investment

Energy Vault Holdings has surged nearly 31% last week, driven by investor optimism over its new projects and a strong future outlook. 

OCGN Stock Tanks After Gene Therapy Trial Update — What Did Ocugen Announce?

Ocugen said 12-month Phase 2 trial data showed its drug OCU410 significantly reduced lesion growth at the dose planned for Phase 3.

Why Is UMAC Stock Falling Today?

Unusual Machines stated that it will issue 8.8 million shares at $17 apiece, a discount of more than 9% to the stock’s closing price on Thursday.

SPDR Series Trust - State Street SPDR S&P Kensho New Economies Composite ETF

Neutral Sentiment

<ul class="summary-bullets"><li>On September 2, the company unveiled a new-generation Li Mega electric MPV, priced at RMB 509,800 for its standard configuration.</li><li>The two drops mark a concentrated push to expand Li Auto’s battery-electric lineup alongside its extended-range L-series SUVs.</li><li>The company is aiming for over 20% delivery growth this year from the 406,000 deliveries reported in 2025.</li></ul><p><br>Shares of Li Auto (LI) rose about 4.5% intraday on Wednesday after the Chinese electric-vehicle maker launched its new flagship battery-electric SUV, the Li i9.</p><p>Li Auto called the i9 “a pioneering flagship family SUV.” The six-seat battery-electric vehicle is priced at RMB 369,800 for its standard configuration. Deliveries begin this week.</p><p>The i9 is Li Auto’s second major product drop in September. On September 2, the company unveiled a new-generation Li Mega electric MPV, priced at RMB 509,800 for its standard configuration. The two drops mark a concentrated push to expand Li Auto’s battery-electric lineup alongside its extended-range L-series SUVs.</p><p>LI stock has edged up 1% so far in September, recovering from a steep 11% drop in August.</p><h2 class="st-heading-2">August Rebound, Full-Year Gap</h2><p>The launches follow a delivery rebound. Li Auto shipped 37,679 vehicles in August, up 32% from a year earlier and ending three straight months of year-on-year declines. Deliveries in the first eight months totaled 261,619, still down 0.6%.</p><p>The company is aiming for over 20% delivery growth this year from the 406,000 deliveries reported in 2025.</p><h2 class="st-heading-2">What’s Next?</h2><p>A refreshed Li i6 SUV launch is due in the fourth quarter with in-house batteries and chips; pre-orders open later this month.</p><p>Li Auto is also rolling out its Mach driver-assistance software, expanding in the Middle East after a Dubai launch of the L9, and preparing a Paris Motor Show debut in October as it enters Europe.</p><h2 class="st-heading-2">How Did LI Retail Traders React?</h2><p>On Stocktwits, retail sentiment around LI stock rose from ‘neutral’ to ‘bullish’ over the past 24 hours, while message volume stayed at ‘normal’ levels.</p><p><a href="https://stocktwits.com/symbol/LI">LI stock</a> has fallen 28% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/apple-reportedly-taps-nvidia-for-m8-ultra-ai-servers-in-enterprise-comeback-push/cZtYZftRBP9">Apple Reportedly Taps Nvidia For M8 Ultra AI Servers In Enterprise Comeback Push</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

People stop by the booth of the Chinese carmaker Li Auto during an auto show in Hangzhou. (Photo credit should read LONG WEI / Feature China/Future Publishing via Getty Images)

Li Auto called the i9 “a pioneering flagship family SUV.” The six-seat battery-electric vehicle is priced at RMB 369,800 for its standard configuration. 

LI Stock Jumps as Li Auto Makes Its Second Launch This Month To Chase 20% Delivery Growth

American Century ETF Trust - Avantis Emerging Markets Equity ETF

SPDR S&P Kensho New Economies Composite ETF

Li Auto Inc - ADR

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$62.46
Prev Close	$64.59
Open	$63.16
Dividend Yield	N/A
50-Day Moving Average	$66.08
Beta	N/A
Avg. Volume	62,728.72
PE Ratio	N/A

52-Week High	$75.61
52-Week Low	$55.69
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

KOMP Fundamentals